MedTrace Logo

Effect of Capacitive Resistive Energy Transfer Therapy on Postmenopausal Women With Frozen Shoulder

NCT07785583 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-08-25

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of capacitive resistive energy transfer therapy on postmenopausal women with frozen shoulder.

Conditions

  • Frozen Shoulder

Interventions

OTHER

Conventional physical therapy

The treatment will involve stretching exercises for the levator scapulae, upper trapezius, pectoralis minor, and pectoralis major muscles. It will also include strengthening exercises for the middle and lower trapezius and the rotator cuff muscles, along with manual therapy techniques such as anteroposterior, posteroanterior, and inferior glides of the shoulder joint.

DEVICE

Capacitive Resistive Energy Transfer (TECAR) therapy

This equipment contains a mobile electrode handled by the therapist, which treats the part affected by the pathology, and a fixed electrode that is in contact with the patient's skin, serving as a conductor. Each patient will be seated in a comfortable position with the affected shoulder exposed, ensuring adequate support and stability throughout the treatment session. The affected shoulder was prepared with a conductive gel to enhance energy transfer. During the session, the capacitive electrode was initially applied, targeting the superficial muscles and tendons around the shoulder joint using circular or linear movements for 5 min. Following this, the resistive electrode was employed to target deeper structures, focusing on the joint capsule and rotator cuff muscles for 10 min. The output power was adjusted based on the patient's tolerance, ensuring a comfortable warm sensation without causing discomfort or burning feeling or pain

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Hossam Hussein, professor · Al-Azhar University

  • Khadega AbdulAziz, Professor · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2027-03-01
Completion
2027-03-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07785583 on ClinicalTrials.gov